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A B S T R A C T
Medical anthropology is a multi-disciplinary approach to the medical sciences and humanities. Immunology is of
the basic medical sciences dealing with anthropology as a science which involves in recognition of self and non-
self. We performed this review paper to introduce the role of immunology in medical anthropology and mole-
cular epidemiology. This narrative review was based on the authors' original experience and current literature.
We discussed about human leukocyte antigens (HLA) and killer-cell immunoglobulin-like receptors (KIR) and
their disease associations. Bioinformatics and biostatistics help us to use this topic in evidence-based medicine.
Immunogenetics is an important part of the molecular anthropology being a part of medical anthropology in
turn. There were different notions of the integration of immunology and medical anthropology including en-
vironmental, ecological and cultural effects, historical and philosophical approaches, immunological biomarkers
in different patients, and immunogenetics. Such studies can be used in pharmacogenomics and personalized
medicine especially for immunotherapy.
1. Introduction
Anthropology has dawned as a science in the British Association of
Anthropology in 1878 through the attempts of Professor Huxley [1].
Anthropology had been defined at least from 1932 as "the study of the
peoples of the simpler cultures in which attention is diverted from
questions of the origin or form of institutions and directed to con-
sideration of how they actually work and what is their meaning and
significance in a given environment" in the word of Professor Radcliffe
Brown's presidential address to the Anthropological Section of the
British Association at its meeting reported by Mr. Driberg's [2].
Medical anthropology is a multi-disciplinary approach to the med-
ical sciences and humanities which mainly consists of the history of
medicine [3], the anatomical characteristics of individuals [4], physical
anthropology [5,6], molecular variations in the immune systems of
individuals [7,8], pharmacogenomics and personalized medicine
[9,10], ecological and spatial studies on disease prevalence and asso-
ciations [11], designing regional guidelines for management of disease
[12], and so on in different ethnicities as well as the cultural, ethical
and religious beliefs of the ethnicities through the lens of cognitive
neuroscience called as neuroaesthetics [13].
Immunology is a basic medical science dealing with anthropology,
because both of these sciences are involved in recognition of self and
non-self [14]. So medical sciences are not alien to anthropology and
offer an ethnographic international classification of ethnicities based on
the immunological molecules [15] such as human leukocyte antigens
(HLA) [7,8], Killer-cell Immunoglobulin-like Receptors (KIR) [7] and a
variety of cluster of differentiation (CD) markers [15]. Other than im-
munologists, the mentioned biomarkers have attracted the viewpoints
of developmental biologists because of a high level of genetic variations
used in archaeology, ontology and paleopathology [16]. Thus the in-
tegration between immunology and anthropology as an example of
integration between the medical sciences and humanities is a strategic
way which enables us to create a biological information bank from
different ethnicities in order to reach the aims mentioned in the present
review such as bone marrow transplantation and finding the identity of
persons not grown with their real parents [7,8], solid organ trans-
plantation in different ethnicities [17], as well as infertility prediction
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Omics and genome wide association studies (GWAS) are the future
of medicine. In GWAS single nucleotide polymorphisms (SNP) as well as
uncommon and emerging mutations are investigated [20]. Medical
anthropology is the theme of such studies. The results of such studies
will be used in pharmacogenomics and personalized medicine [21].
According to this rationale, we performed this review paper to in-
troduce the role of immunology in medical anthropology.
3. Evidence acquisition
The present work is a narrative review based on the authors' ex-
perience and current literature. The search strategy was using key
words and phrases such as "anthropology AND immunology", "anthro-
pology AND HLA" and so forth.
Through searching in web of science core collection (WOS) relevant
papers were founded in the time period of 1983-2017. The search was
performed on 1 April 2017 (Table 1). In order to find older papers we
used PubMed, Google and Google Scholar.
As the search result, we found few exactly related records that most
of them had been published in Nature and other nature publishing
group journals. The oldest one was for 1901 entitled "anthropology"
published in Scientific American [1] and the latest one is an article
published in Nature in 2016 about anthropology [57]. However, the
oldest well-related article was for 1949 under the title of "Systematics,
Evolution, and Anthropology in the Light of Immunology" published in
The Quarterly Review of Biology [22]. The situation and impact of the
term "medical anthropology" in global scientific production is not ac-
ceptable; because this term has been repeated in titles of just 263 WOS
papers at the time of our search (Table 2).
4. Narrative review of the literature
Sanchez-Mazas et al. introduced immunogenetics as a tool in an-
thropological studies. They accounted ABO blood grouping system (in
1900) as the history of role of immunology in anthropology [48].
William Clouser Boyd was a well-known American biochemist
(1903–1984) [58]. In 1949 he published a paper under the title of
"Systematics, Evolution, and Anthropology in the Light of Im-
munology". In that paper he believed that taxonomy is associated with
cellular antigens like blood group related molecules [22]. Then in 1958,
he and Isaac Asimov wrote a book entitled "races and people". This book
consisted of Mendelian genetics, inheritance patterns, basics of blood
transfusion, language families, and a lot of things known today [59]!
Based on search in PubMed, the term "medical anthropology" was firstly
used in 1952 by Gomez [60]. In 1962 Roney as another pioneers of this
term believed that medical anthropology play its role through 1) giving
insights to the participants of medical fields, 2) altering behavior in
order to control disease, and 3) predicting the direction and rate of
culture change. As well history of medicine had been accounted as
another part of medical anthropology [61].
In 1990 Emily Martin in a paper entitled "Toward anthropology of
immunology" compared immune system with a nation state. In other
words body cells were like citizens of a city, and since anthropology
was a study on individuals of a region, immunology would be an an-
thropological study on immune cells. The key concept of this similarity
from her viewpoint was "self and non-self" distinguish [24].
In 1993 human genome project was reminded as an example of
using genetics and immunology in medical anthropology. It had been
suggested that technologies such as polymerase chain reaction (PCR)
could be used in bio-politics [28]. Parham as another pioneer of this
topic published a paper entitled "HLA, anthropology and transplanta-
tion". He believed that HLA typing using PCR with sequence specific
primers (PCR-SSP) was more accurate than serology [41].
In 1996 Petrov and Ulyankina wrote an essay about E. Metchnikoff
(1845–1916) a Russian biologist and winner of Nobel Prize in 1908. His
fame was for discovery of macrophages (1882). He had published an
essay about anthropology and proposed the theory of orthobiosis [34].
Orthobiosis is a multidisciplinary approach to lifestyle and well-being
[62,63].
Molecular study on burnt bone fragments had been an approach to
immunological anthropology. In 1999 Cattaneo et al. published a study
because they believed that finding out human or non-human origin of
such bones are not possible through morphology and gross anatomy.
They were trying to extract human albumin and human mitochondrial
DNA from powder of the bones burnt at 800–1200 °C [26].
In 2000 Sharp had an anthropological approach to body parts
commodification and then discussed about its genetics and immunology
[35]. In another paper published in 2000, Sumara mentioned that
complexity theory can be used in ecology, psychology, neurology, an-
thropology and immunology [36].
In 2001 Antonio Arnaiz-Villena as a pioneer of HLA typing, pub-
lished a paper about association of languages and HLA genetics. He and
Table 1
Founded papers in WOS.
Search in WOS core collection Results Time range of the results
TITLE: ("medical anthropology" AND immunology) No result –
TITLE: (anthropology AND immunology) [22–24] 1990–2012
TOPIC: ("medical anthropology" AND immunology) [14] 2012
TOPIC: (anthropology AND immunology) [7,14,15,25–37] 1990–2017
TITLE: (anthropology AND HLA) [38–43] 1993–2015
TOPIC: (anthropology AND HLA) 93 results 1991–2017
TITLE: (anthropology AND KIR) [40,44] 2009
TOPIC: (anthropology AND KIR) [40,44–48] 2006–2015
TITLE: (anthropology AND immunogenetics) No result –
TOPIC: (anthropology AND immunogenetics) [25,37,45,47–56] 2001–2016
Total with exclusion of duplications + other than WOS papers [7,14,15,22–48] (N=30) 1990–2017
Table 2
The impact of medical anthropology in global science production.
Search in WOS core collection Results Time range of the results h index
TOPIC: ("medical anthropology") 770 results 1983–2017 44
TITLE: ("medical anthropology") 263 results 1983–2017 20
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his coworkers used HLA profile (-A, -B, -DRB1 and -DQB1) in order to
design neighbor-joining tree. Evaluation of HLA class I alleles (-A and
-B) were low resolution and HLA class II alleles (-DRB1 and -DQB1)
were high resolution [25].
In 2003 McDade believed that mechanisms such as development,
plasticity and adaptation were central concepts of biological anthro-
pology; on the other hand such concepts were associated with im-
munology. As well he had an ecological approach to immunology. For
example ecology of nutrition, ecology external diseases and molecular
ecology of microorganisms affect immune system of human [31].
In 2004 Helmberg et al. in a conference paper mentioned HLA
typing data as an example of medical anthropology [39].
In 2006 Frassati et al. mentioned that KIR typing both at content
level (loci) and at allelic level (locus) can be used in genetic association
and anthropological studies [46].
In 2007 on the occasion of investigation of HLA gene diversity in
two ethnic groups of southeast of Iran, it was announced that HLA
typing studies can be used both in anthropology and clinical practice
[30].
In 2009 Hollenbach and Middleton reported an abstract from 15th
international histocompatibility workshop about anthropology of KIR
[40,44]. Buhler et al. performed a study on polymorphism of KIR2DL4
locus [KIR genes have loci and each locus can be polymorphic in turn].
They believed that KIR2DL4 polymorphism can be a good candidate for
anthropology [45].
In 2011 milk synthesis in primates was investigated from the
viewpoint of nutrition, biology and anthropology. Although this paper
was not directly about immunology and medical anthropology, but on
the occasion of immune-factors existence in milk, the immunological
and anthropological approaches were discussed inside each other [29].
Thorsby mentioned that HLA can be used in pharmacogenomics of
vaccination, transplantation and autoimmune diseases. The author
mentioned that anthropological role of HLA had been shown in the 5th
international histocompatibility workshop (1970–1972). High resolu-
tion genomic typing resulted in advances in this field during recent
years [37].
In 2012 Moulin added a comment on the paper of Napier entitled
"NONSELF HELP: How immunology might reframe the enlightenment"
[14]. In this note, she suggested "selfhood" instead of "self / non-self"
paradigm [32]. Parker et al. design a review on the role of modern
immunology in pandemics of non-infectious diseases in this industrial
world. According to biological, anthropological and ecological ap-
proaches, they account this pandemics as a consequence of "loss of
human biome" especially helminthes depletion and vitamin D defi-
ciency [33].
In 2015 Rey et al. preformed an HLA typing study in Turkmen po-
pulation of northwest of Iran bordering Turkmenistan. The theme of the
article was based on transplantation, pharmacogenomics and anthro-
pology. This work was reported in 2 congresses as well [38,42,43].
Gonzalez-Galarza et al. reported 2015 update allele frequency net da-
tabase (AFND) [AFND is available from http://www.allelefrequencies.
net]. AFND had been established in 2003. It can be used in
pharmacogenomics and anthropology; e.g. in adverse drug reaction
database [47].
In 2016 Gilbert and Tauber had a philosophical approach to im-
munology. They believed that historically, immunology had been pre-
viously affiliated with biology of individuals, and nowadays has be-
come a science concerned with the biology of communities. As well
they believed that the balance of immune rejection and immune tol-
erance plays an important role in interaction of individuals with other
organisms and their surrounding ecosystem [27].
In the most recent article having both keywords of immunology and
medical anthropology AFRIBIOTA project was discussed. This project is
a large study in Africa about pediatric environmental enteropathy.
Their anthropological approach was related to environmental factors.
The authors believed that gastrointestinal diseases are associated with
imbalance of gut immune system and normal microbial flora [64].
5. HLA and medical anthropology
In mankind, HLA gene is located on chromosome 6p21.3 with the
length of 3600 kb and has 239 antigenic loci that approximately 40% of
them are immunogenic [65]. There are 2 classes of HLA. The class I in
turn falls in two categories of classical (HLA-A, -B and -C) expressed in
all the nuclear cells of body and non-classical (HLA-G, E and F) ex-
pressed on the surface of specific cells like trophoblasts (Fig. 1) [19].
The main role of HLA class I is acting as the identifying cards of self-
cells causing immune-tolerance. In order to do that, some of these
biological molecules perform the function of identifying card for nu-
clear cells of body to be proposed for the KIRs expressed on the surface
of natural killer (NK) cells (CD56CD16). Different polymorphic re-
ceptor-ligand interactions in different individuals and ethnicities result
in different useful, harmless and harmful outcomes. Some other HLA
class I molecules (A and B) play their role through interaction with
cytotoxic T lymphocytes (CTL). Both NK cells and CTL monitor nuclear
cells of body dynamically [66].
Since some alleles of HLA are commonplace in specific ethnicities,
the alleles are used by anthropologists as biomarkers to detect genetic
interactions in that populations. Clinically, being acquainted with HLA
distribution is necessary for forensic medicine, transplantation and
bone marrow donating centers [67,68], and studies of HLA related
diseases (whether infectious agents [69–72] or autoimmune diseases
[73]).
HLA is inherited as haplotype form (Fig. 1). All genes of this hap-
lotype are necessary for survival. Each gene has allelic polymorphism in
turn (Fig. 2). Individual variations are in such alleles (not in presence or
absence of the very genes unlike KIR).
There are different research and clinical methods for evaluation of
HLA genotypes and HLA typing including serology, PCR-SSP, and se-
quencing methods including next generation sequencing (NGS), Sanger
and high resolution melting (HRM). Each method has pros and cons.
Serology is the less accurate method, however it can show the current
clinical phenotype of patients. For example in ankylosing spondylitis
HLA-B27 seropositivity is investigated, however genetic investigation
Fig. 1. Choromosome 6P21.3, HLA loci. Tumor necrosis factor (TNF) is another polymorphic gene in this loci. Each of these genes can have allelic polymorphisms in
turn. Centromeric end is at the left (short arm of the chromosome) [originally designed].
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may result in detection of a genetic positivity not having serological
manifestation (Of course many researchers consider this feature of ge-
netic evaluation as an advantage for prediction of the disease [74]).
Conventional PCR with restriction enzyme is not useful, because HLA
genes are highly polymorphic. PCR-SSP is accurate enough, however it
is moneys-taking and times-consuming for complete HLA typing due to
a large number of specific primers. Among sequencing methods NGS
and Sanger can be used for complete HLA typing as well as using for
GWAS, however for detection of some previously selected variants
(such as HLA-B13:01 and -B31:01 in pharmacogenomics of adverse
drug reaction [75,76]) HRM is an economical, rapid and simple technic
using NanoDrop spectrophotometer and real-time PCR [77].
6. KIR and medical anthropology
KIRs are receptors of NK cells. These cells are a subset of lymphoid
progenitor comprising about 10–15% of peripheral blood total lym-
phocytes [78]. NK cells mainly perform their function in innate im-
munity as well as adaptive immune responses by killing their target
cells and production of different cytokines [79]. Among NK cell subsets,
there are mainly CD16+CD56dim and CD16−CD56bright NK cells; the
dim form has further cytotoxic capacity called as "cytotoxic NK cell",
and the bright form performs its function in secretion of inflammatory
cytokines called as "immune-regulatory NK cell". Both of them express
KIR, but the dim form express more. Bright NK cells are also called as
uterine or decidual NK cells [18,19,78].
KIRs are one of the markers on NK cell surface proteome, and si-
milar to HLAs, they are inherited as haplotype form [79]. KIR gene
cluster is located on chromosome 19q13.4 within the leukocyte re-
ceptor complex (LRC). This cluster has a centromeric and a telomeric
region [80]. KIR gene cluster has 14 genes and 2 pseudo-genes in which
8 of them encode inhibitory proteins and 6 of them encode activating
proteins [18]. The encoded proteins expressed on surface of NK cells
interact with the HLA class I (especially -C, -G, and Bw) existing on
surface of the other nucleated cells of human. In inhibitory interactions,
the result is immune tolerance if the target cells be healthy, and
otherwise they result is cytotoxic activity of NK cells against the can-
cerous or viral infected target cells (called as the "missing-self hy-
pothesis" which is due to down regulation HLA molecule expression).
Unlike to HLA, having all of these genes are not necessary for survival,
and every individual can have some of them [81]. Considering that HLA
is the most polymorphic loci in human genome and as well KIR has
different types of alleles for each gene, different interactions of KIR-
HLA can be associated with different diseases (susceptibility or pro-
tection) like autoimmune diseases and cancers among different ethni-
cities and populations; this, is called "disease association" in medical
anthropology [7].
Such associations are not necessarily cause-effect associations. For
example, KIR2DS4 is an activating gene existing also in inhibitory
haplotypes. Hence its associations with some variables may be due to
the accompanied inhibitory genes. From the viewpoint of biostatistics,
it can be a kind of alpha error. In addition, none of these genes are not
specific for any specific disease. From the view point of philosophy of
medicine, although such genes may have high amounts of odds ratios
and relative risks with some diseases, but they have not necessarily
enough amounts of absolute risk or positive predictive values.
Based on the number of extracellular immunoglobulin domains,
KIRs are categorized in two groups (2D and 3D). The two functional
types of KIR, i.e. inhibitory and activating, are distinguished depending
on the length of their intracellular domains. Inhibitory KIRs (iKIRs) are
characterized by their long intra-cytoplasmic tail (distinguished by an
‘L’ in their name) and presence of at least one immunoreceptor tyrosine-
based inhibitory motif (ITIM). Activating KIRs (aKIR) are characterized
by their short intra-cytoplasmic tail (distinguished by an ‘S’ in their
name) and absence of ITIM. ITIM is a protein triggers inhibitory cascade
in cytoplasm [82]. iKIRs are 2DL1-2DL5 and 3DL1-3, and aKIRs are
2DS1-2DS5 and 3DS1. The pseudogenes are of KIR2DP1 and KIR3DP1
that do not encode any functional KIR molecule. KIR2DL4 exists in all
individuals with both inhibitory and activating functions, but more of
inhibitory. The genes 3DL3 and 3DL2 are always located at centromeric
and telomeric tails of this cluster respectively. These genes are called
frame work genes (Fig. 3) [81].
As we mentioned, although KIRs are inherited as haplotype forms,
but unlike HLA, having all of them is not necessary for survival. There
are four main groups of KIR haplotypes which are defined based on
gene content termed as haplotypes A (centromeric A and telomeric A)
and B (centromeric B and telomeric B) (Fig. 3). Uncommon haplotypes
are named with X. Patients with AA genotypes have uniform in gene
content which is composed of five inhibitory genes (KIR2DL1, 2DL3,
3DL1, 3DL2 and 3DL3), one activating gene (KIR2DS4), and the
KIR2DL4 which may have both inhibitory and activating capacity. In-
terestingly, many A haplotypes possess null variants of both KIR2DS4
and KIR2DL4 that are not expressed on the cell surface. Such in-
dividuals may have not any functional aKIR gene. The B haplotypes
contain variable numbers of both activating and inhibitory genes and
are the primary contributors to the extraordinary differences in KIR
gene profiles observed in distinct ethnicities across the world [83].
Fig. 2. Nomenclature of HLA allelic polymorphisms [Adapted from [47] and
originally redesigned].
Fig. 3. Chromosome 19q23, KIR loci. The green genes are present in all people
(except 2DP1); therefore they have not anthropological value at gene level
(however 2DL4 is polymorphic at allelic level). Blue genes are inhibitory and
red genes are activating. In the purple locus, 3DL1 is inhibitory and 3DS1 is
activating. The ligand of 2DS2 is unknown, but seems to be HLA-C1 (or C1
associated) [84,85]. The ligand of 3DL1 is HLA-Bw4, but the ligand of 3DS1 in
unknown (in some papers HLA-Bw4 is considered) [85]. The sizes are not real
[originally designed]. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article).
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7. Enviromics in molecular anthropology
Eviromics is a study of the envirome and exposome which are a set
of different internal and external factors affecting genetic and immune
system. Immune cells can be affected by many of such factors including
food and nutrition. Like GWAS, there are studies known as longitudinal
epigenome-wide, evirome-wide and exposome-wide association studies
(LEWAS) [86]. Such interdisciplinary works provide the needed mate-
rials for personalized medicine. Global changes and human-associated
microbes affect early life development of immune system. Adulthood
health is correlated with the childhood health affected by early meta-
bolic programming and early immune programming. Food and nutri-
tion, antibiotics, vaccination, sunlight exposure and vitamin D status
(as described by Parker et al. [33]) and so on influence on early me-
tabolic and immune programming. Primary microbial exposure results
in development of pattern recognition receptors (like toll-like receptors)
and T helper cells. All of these together show the role of anthropology
in development of immune system [87]. Environment wide association
studies (EWAS) are also notable in human health. Association of food
web with human health and children development is discussed in this
field [88]. The final phenotype of each individual is made up of all of
the factors investigated in GWAS, EWAS and LEWAS [89,90].
8. Molecular pathological epidemiology
Molecular pathological epidemiology (MPE) is a term used to in-
tegrate epidemiology and health sciences with immunopathological
basis of diseases. Such studies are also named immunology-MPE re-
search. Other than pure genetic basis of disease, nutrition, diet and
environmental factors influence genomics and epigenomics of immune
cells. In MPE research biostatistics and bioinformatics are used in im-
munology and pathology. The results of such researches can be used in
precision (personalized) medicine. In immunology-MPE model of re-
search immunological biomarkers (including receptors, ligands and
secretory factors) such as programmed cell death 1 (PD1) and its ligand
(PD-L1), CD markers, KIR and HLA subtypes, interleukins and other
cytokines are investigated. The results will be used in immunotherapy
and targeted therapy [91,92].
9. Evidence-based medicine in molecular anthropology
It needs a way to link molecular anthropology to clinical practice.
Bioinformatics and biostatistics help us to reach this aim as the tools of
evidence-based medicine (EBM). From the viewpoint of philosophy of
medicine, basic medical sciences (based on causation relationship) and
clinical medical sciences and practice (based on EBM), both help each
other [93–97]. Molecular anthropology is an example of this integra-
tion [98,99]. A controversy is that molecular anthropology is used in
personalized medicine, but on the other hand EBM is based on epide-
miology (not a single person). The question existed is that how perso-
nalized medicine can be evidence-based. The answer is that the pieces
of evidence obtained from epidemiological studies are subjected to be
used in per case decisions. This controversy is currently resolved
(Fig. 4) [92].
The way of using medical anthropology in clinical practice, starts
from international and regional bioinformatics databases. The raw data
can be used for disease association and pharmacogenomics study. Such
observational studies are performed according to the guideline
strengthening the reporting of observational studies in epidemiology
(STROBE) (available from https://www.strobe-statement.org). In ge-
netic association studies, other than STROBE, another guideline entitled
strengthening of genetic association studies (STREGA) should be re-
garded [100]. If in a genetic association study, the gene is HLA or KIR
(immunogenetic studies), another guideline should also be regarded
entitled strengthening the reporting of immunogenetic studies (STREIS)
[101]. These guidelines help researchers to unify their studies as a
check list; because these studies are supposed to be used in meta-ana-
lyses. At the next step, the results of observational studies as raw pieces
of evidence can be used in interventional studies. Finally the results of
clinical trials (or meta-analyses of clinical trials) can be used in clinical
practice.
10. Conclusion
Immunology is an important part of the molecular anthropology
being a part of medical anthropology in turn. There were different
notions of the integration of immunology and medical anthropology
including environmental, ecological and cultural effects, historical and
philosophical approaches, the molecular fingerprints of immune
system, immunological biomarkers in different patients, and im-
munogenetics. Such studies can be used in pharmacogenomics and
personalized medicine especially for immunotherapy.
Conflicts of interest
We declare that there is no personal, commercial, cultural and
governmental conflicts of interest. There may be potential conflict of
interest for the named journals, websites and persons; however we deny
any relationship.
Acknowledgements
We thank Lorestan and Iran Universities of Medical Sciences for
their scientific supports. There was no funding or grant.
References
[1] D. Cunninghaiif, Anthropology, Sci. Am. 52 (1901) 21624–21625.
[2] J. Driberg, Anthropology, Nature (1932).
[3] H. Yarmohammadi, B. Dalfardi, J. Rezaian, A. Ghanizadeh, Al-Akhawayni’s de-
scription of pulmonary circulation, Int. J. Cardiol. 168 (2013) 1819–1821.
[4] B. Nikitiuk, Anatomy and anthropology, Arkhiv anatomii, gistologii i embriologii
79 (1980) 5–14.
[5] P.T. Ellison, The evolution of physical anthropology, Am. J. Phys. Anthropol. 165
(2018) 615–625.
[6] R. Jurmain, L. Kilgore, W. Trevathan, E. Bartelink, R.L. Ciochon, Introduction to
physical anthropology, Nelson Educ. (2017).
[7] F. Shahsavar, A.M. Varzi, S.A.Y. Ahmadi, A genomic study on distribution of
human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran,
Genom. Data 11 (2017) 3–6.
[8] A.M. Varzi, F. Shahsavar, M.J. Tarrahi, Distribution of HLA-DRB1 and HLA-DQB1
alleles in lak population of Iran, Hum. Immunol. 77 (2016) 580–583.
[9] E. Elhaik, L. Yusuf, A.I. Anderson, M. Pirooznia, D. Arnellos, G. Vilshansky,
G. Ercal, Y. Lu, T. Webster, M.L. Baird, The diversity of recent and ancient human
(DREAM): a new microarray for genetic anthropology and genealogy, forensics,
and personalized medicine, Genome Biol. Evol. 9 (2017) 3225–3237.
Fig. 4. Immunology, medical anthropology and epidemiology are integrated
and imported to GWAS, EWAS and LEWAS. Using evidence-based medicine, the
results will be used in personalized medicine [originally designed].
S.A.Y. Ahmadi et al. Biomedicine & Pharmacotherapy 109 (2019) 2203–2209
2207
[10] M. Pirmohamed, Personalized pharmacogenomics: predicting efficacy and adverse
drug reactions, Annu. Rev. Genomics Hum. Genet. 15 (2014) 349–370.
[11] K. Anbari, A. Hasanvand, R. Shirzadegan, S. Ahmadi, An ecological analysis on
seroprevalence of Helicobacter pylori IgG among Iranian general population, J.
Prev. Epidemiol. 3 (2018) e02.
[12] B. Khodadadi, N. Mousavi, M. Mousavi, P. Baharvand, S.A.Y. Ahmadi, Diagnosis
and predictive clinical and para-clinical cutoffs for diabetes complications in Lur
and Lak populations of Iran; a ROC curve analysis to design a regional guideline, J.
Nephropharmacol. 7 (2018) 83–89.
[13] S.A.Y. Ahmadi, J. Rezaian, M. Almasian, A. Farhadi, Hermeneutics of art and
poetry through the Lens of neuroscience: letter to editor, Arch. Neurosci. 4 (2017)
e33048.
[14] A.D. Napier, Nonself help: how immunology might reframe the Enlightenment,
Cult. Anthropol. 27 (2012) 122–137.
[15] A. Cambrosio, P. Keating, A matter of FACS: constituting novel entities in im-
munology, Med. Anthropol. Q. 6 (1992) 362–384.
[16] Anthropology: ancient genomes from tooth plaque, Nature 531 (2016) 553-553.
[17] D. Amélie Lagou, K.C. Ackoundou-N’guessan, P. Albert Coulibaly, M. Cyr Guei,
K. Aristophane Tanon, M. Traoré, W. Mélanie Tia, M. Moudachirou, D. Apollinaire
Gnionsahe, Renal transplant in human immunodeficiency virus positive dialysis
patients; report of four cases in French-speaking Sub-Saharan Africa and review of
literature, Immunopathol. Persa 4 (2018) e177-e117.
[18] S. Akbari, S.A.Y. Ahmadi, F. Shahsavar, The relationship of maternal KIR and
parental HLA-C genes with risk of recurrent spontaneous abortion: a regional
study in Lorestan Province, Iran, Crescent J. Med. Biol. Sci. 5 (2018) 194–197.
[19] S.A.Y. Ahmadi, F. Shahsavar, S. Akbari, A review on controversies about the role
of immune and inflammatory systems in implantation process and durability of
pregnancy, Int. J. Women’s Health Reprod. Sci. 4 (2016) 96–102.
[20] M. Fareed, M. Afzal, Single nucleotide polymorphism in genome-wide association
of human population: a tool for broad spectrum service, Egypt. J. Med. Hum.
Genet. 14 (2013) 123–134.
[21] M.G. Gopisankar, CYP2D6 pharmacogenomics, Egypt. J. Med. Hum. Genet. 18
(2017) 309–313.
[22] W.C. Boyd, Systematics, evolution, and anthropology in the light of immunology,
Q. Rev. Biol. 24 (1949) 102–108.
[23] J. BUETTNER‐JANUSCH, Physical anthropology: the chimpanzee: volume III:
immunology, infections, hormones, anatomy, and behavior of chimpanzees, GH
BOURNE, Am. Anthropol. 74 (1972) 145–146.
[24] E. Martin, Toward an anthropology of immunology: the body as nation state, Med.
Anthropol. Q. 4 (1990) 410–426.
[25] A. Arnaiz-Villena, J. Martinez-Laso, J. Alonso-Garcia, The correlation between
languages and genes: the Usko-Mediterranean peoples, Hum. Immunol. 62 (2001)
1051–1061.
[26] C. Cattaneo, S. DiMartino, S. Scali, O.E. Craig, M. Grandi, R.J. Sokol, Determining
the human origin of fragments of burnt bone: a comparative study of histological,
immunological and DNA techniques, Forensic Sci. Int. 102 (1999) 181–191.
[27] S.F. Gilbert, A.I. Tauber, Rethinking individuality: the dialectics of the holobiont,
Biol. Philos. 31 (2016) 839–853.
[28] D. Heath, P. Rabinow, An introduction to BIO-POLITICS - the anthropology of the
new genetics and Immunology, Cult. Med. Psychiatry 17 (1993) 1–2.
[29] K. Hinde, L.A. Milligan, Primate milk: proximate mechanisms and ultimate per-
spectives, Evol. Anthropol. 20 (2011) 9–23.
[30] H.A. Khazaei, N. Rezaei, A. Aghamohammadi, A.A. Amirzargar, K.M. Ghasemi,
I. MiriMoghaddam, B. Nikbin, Human leukocyte antigen profile of two ethnic
groups in southeast of Iran, Iran. J. Allergy Asthma Immunol. 6 (2007) 223–224.
[31] T.W. McDade, Life history theory and the immune system: steps toward a human
ecological immunology, Yearb. Phys. Anthropol. 46 (46) (2003) 100–125.
[32] A.M. Moulin, Immunology, a dubious ally of anthropology? A comment on David
Napier’s "Nonself Help: how immunology might reframe the enlightenment", Cult.
Anthropol. 27 (2012) 153–161.
[33] W. Parker, S.E. Perkins, M. Harker, M.P. Muehlenbein, A prescription for clinical
immunology: the pills are available and ready for testing. A review, Curr. Med.
Res. Opin. 28 (2012) 1193–1202.
[34] R.V. Petrov, T.I. Ulyankina, The genius of E. E. Metchnikoff - discoveries over the
centuries, Biosci. Rep. 16 (1996) 189–205.
[35] L.A. Sharp, The commodification of the body and its parts, Annu. Rev. Anthropol.
29 (2000) 287–328.
[36] D.J. Sumara, Researching complexity, J. Lit. Res. 32 (2000) 267–281.
[37] E. Thorsby, On the future of HLA, Tissue Antigens 78 (2011) 229–240.
[38] A. Arnaiz-Villena, A. Amirzargar, C. Areces, M. Enriquez-de-Salamanca, J. Marco,
S. Abd-El-Fatah-Khalil, M. Fernandez-Honrado, E. Muniz, J.M. Martin-Villa,
D. Rey, Gorgan (Turkmen in Iran) HLA genetics: transplantation, pharmacoge-
nomics, and anthropology, Am. J. Hum. Biol. 27 (2015) 259–260.
[39] W.M.C. Helmberg, M.L. Feolo, D.J. Hoffman, S. Mack, HLA typing data of the
IHWG anthropology project at DBMHC, Genes Immun. 5 (2004) S55-S55.
[40] J.A. Hollenbach, D. Middleton, Further evidence for the co-evolution of KIR and
HLA: report from the KIR Anthropology component of the 15th International
Histocompatibility Workshop, Tissue Antigens 73 (2009) 400–401.
[41] P. Parham, Hla, anthropology, and transplantation, Transplant. Proc. 25 (1993)
159–161.
[42] D. Rey, A. Amirzargar, C. Areces, M. Enriquez-de-Salamanca, J. Marco, S. Abd-El-
Fatah-Khalil, M. Fernandez-Honrado, E. Muniz, J.M. Martin-Villa, A. Arnaiz-
Villena, Gorgan (Turkmen in Iran) HLA genetics: transplantation, pharmacoge-
nomics and anthropology, Immunol. Invest. 44 (2015) 88–100.
[43] D. Rey, A.A. Amirzargar, C. Areces, M. Enriquez-de-Salamanca, J. Alonso-Rubio,
S. Abd-El-Fatah-Khalil, M. Fernandez-Honrado, L. Barbolla, J.M. Martin-Villa,
A. Arnaiz-Villena, Gorgan (TURKMEN in Iran) HLA genetics: transplantation,
pharmacogenomics and Anthropology, Tissue Antigens 84 (2014) 126-126.
[44] J. Hollenbach, D. Middleton, Report from the KIR anthropology component of the
15th international histocompatibility workshop, Hum. Immunol. 70 (2009) S8-S8.
[45] S. Buhler, J. Di Cristofaro, C. Frassati, A. Basire, V. Galicher, J. Chiaroni, C. Picard,
High levels of molecular polymorphism at the KIR2DL4 locus in French and
Congolese populations: impact for anthropology and clinical studies, Hum.
Immunol. 70 (2009) 953–959.
[46] C. Frassati, M. Touinssi, C. Picard, M. Segura, V. Galicher, K. Papa, K. Gagne,
E. Vivier, A. Degioanni, G. Botsch, P. Mercier, F. Vely, P. de Micco, D. Reviron,
J. Chiaroni, Distribution of killer-cell immunoglobulin-like receptor (KIR) in
Comoros and Southeast France, Tissue Antigens 67 (2006) 356–367.
[47] F.F. Gonzalez-Galarza, L.Y.C. Takeshita, E.J.M. Santos, F. Kempson, M.H.T. Maia,
A.L.S. da Silva, A. Silva, G.S. Ghattaoraya, A. Alfirevic, A.R. Jones, D. Middleton,
Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease
and HLA adverse drug reaction associations, Nucleic Acids Res. 43 (2015)
D784–D788.
[48] A. Sanchez-Mazas, M. Fernandez-Vina, D. Middleton, J.A. Hollenbach, S. Buhler,
D. Di, R. Rajalingam, J.M. Dugoujon, S.J. Mack, E. Thorsby, Immunogenetics as a
tool in anthropological studies, Immunology 133 (2011) 143–164.
[49] E. Arrieta-Bolanos, H. Maldonado-Torres, O. Dimitriu, M.A. Hoddinott, F. Fowles,
A. Shah, P. Orlich-Perez, A.J. McWhinnie, W. Alfaro-Bourrouet, W. Bujan-Boza,
A.M. Little, L. Salazar-Sanchez, J.A. Madrigal, HLA-A, -B, -C,-DQB1, and-
DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley
Population and its relationship to worldwide populations, Hum. Immunol. 72
(2011) 80–86.
[50] S.W. Chen, Q.S. Hu, Y. Xie, L.J. Zhou, C.J. Xiao, Y.P. Wu, A.L. Xu, Origin of Tibeto-
Burman speakers: evidence from HLA allele distribution in Lisu and Nu inhabiting
Yunnan of China, Hum. Immunol. 68 (2007) 550–559.
[51] P.P.J. Dunn, G. Lamb, C. Selwyn, J. Compton, E. Yang, M. Maiers, M. Fernandez-
Vina, Diversity in exon 5 of HLA-C*04:01:01G is significant in anthropological
studies, Hum. Immunol. 77 (2016) 426–428.
[52] S.J. Mack, A. Sanchez-Mazas, R.M. Single, D. Meyer, J. Hill, H.A. Dron, A.J. Jani,
G. Thomson, H.A. Erlich, Population samples and genotyping technology, Tissue
Antigens 69 (2007) 188–191.
[53] C.M. Shen, B.F. Zhu, S.H. Ye, M.L. Liu, G.A. Yang, S. Liu, H.X. Qin, H.D. Zhang,
R. Lucas, S.B. Li, Allelic diversity and haplotype structure of HLA loci in the
Chinese Han population living in the Guanzhong region of the Shaanxi province,
Hum. Immunol. 71 (2010) 627–633.
[54] R.M. Single, D. Meyer, S.J. Mack, A. Lancaster, H.A. Erlich, G. Thomson, 14th
international HLA and immunogenetics workshop: report of progress in metho-
dology, data collection, and analyses, Tissue Antigens 69 (2007) 185–187.
[55] O.D. Solberg, S.J. Mack, A.K. Lancastera, R.M. Single, Y. Tsai, A. Sanchez-Mazas,
G. Thomson, Balancing selection and heterogeneity across the classical human
leukocyte antigen loci: a meta-analytic review of 497 population studies, Hum.
Immunol. 69 (2008) 443–464.
[56] G. Sulcebe, E. Shyti, HLA-A, -B, -C,-DRB1 and-DQB1 allele and haplotype fre-
quencies in a population of 432 healthy unrelated individuals from Albania, Hum.
Immunol. 77 (2016) 620–621.
[57] D.D.P. Johnson, Anthropology: hand of the gods in human civilization, Nature 530
(2016) 285–287.
[58] A Dictionary of Scientists Oxford University Press, (2003) Available from: http://
www.oxfordreference.com/view/10.1093/oi/authority.20110803095522436
eISBN: 9780191726835.
[59] W.C. Boyd, I. Asimov, Races and People, (1958).
[60] A.L. Gomez, Medical anthropology, El Dia medico 24 (1952) 974–976.
[61] J.G. Roney, Medical anthropology: an introduction, J. Med. Assoc. 55 (1963)
95–99.
[62] W.D. Sorochan, Health concepts as a basis for orthobiosis, J. Sch. Health 38 (1968)
673–682.
[63] A.S. Sethi, Orthobiosis: an interdisciplinary approach, J. Sch. Health 40 (1970)
396–400.
[64] P. Vonaesch, R. Randremanana, J.C. Gody, J.M. Collard, T. Giles-Vernick,
M. Doria, I. Vigan-Womas, P.A. Rubbo, A. Etienne, E.J. Andriatahirintsoa,
N. Kapel, E. Brown, K.E. Huus, D. Duffy, B.B. Finlay, M. Hasan, F.A. Hunald,
A. Robinson, A. Manirakiza, L. Wegener-Parfrey, M. Vray, P.J. Sansonetti,
Identifying the etiology and pathophysiology underlying stunting and environ-
mental enteropathy: study protocol of the AFRIBIOTA project, BMC Pediatr. 18
(2018) 236.
[65] S. Khansa, R. Hoteit, D. Shammaa, R.A. Khalek, H. El Halas, L. Greige, F. Abbas,
R.A. Mahfouz, HLA class I allele frequencies in the Lebanese population, Gene 512
(2013) 560–565.
[66] R. Rajalingam, Human diversity of killer cell immunoglobulin-like receptors and
disease, Korean J. Hematol. 46 (2011) 216–228.
[67] Z. Grubic, M. Burek Kamenaric, M. Mikulic, K. Stingl Jankovic, M. Maskalan,
R. Zunec, HLA-A, HLA-B and HLA-DRB1 allele and haplotype diversity among
volunteer bone marrow donors from Croatia, Int. J. Immunogenet. 41 (2014)
211–221.
[68] P.A. Gourraud, M.L. Balere, C. Faucher, P. Loiseau, A. Dormoy, E. Marry,
F. Garnier, HLA phenotypes of candidates for HSCT: comparing transplanted
versus non-transplanted candidates, resulting in the predictive estimation of the
probability to find a 10/10 HLA matched donor, Tissue Antigens 83 (2014) 17–26.
[69] F. Shahsavar, T. Mousavi, A. Azargoon, K. Entezami, Association of
KIR3DS1+HLA-B BW4lle8 combination with susceptibility to tuberculosis in lur
population of Iran, Iran. J. Immunol. 9 (2012) 39–47.
[70] P.J. McLaren, M. Carrington, The impact of host genetic variation on infection
S.A.Y. Ahmadi et al. Biomedicine & Pharmacotherapy 109 (2019) 2203–2209
2208
with HIV-1, Nat. Immunol. 16 (2015) 577–583.
[71] S.A. Migueles, M. Connors, Success and failure of the cellular immune response
against HIV-1, Nat. Immunol. 16 (2015) 563–570.
[72] E.B. Clemens, E.J. Grant, Z. Wang, S. Gras, P. Tipping, J. Rossjohn, A. Miller,
S.Y.C. Tong, K. Kedzierska, Towards identification of immune and genetic corre-
lates of severe influenza disease in Indigenous Australians, Immunol. Cell Biol. 94
(2016) 367–377.
[73] N. Tajik, F. Shahsavar, H. Poormoghim, M.F. Radjabzadeh, T. Mousavi, A. Jalali,
KIR3DL1+HLA-B Bw4 Ile80 and KIR2DS1+HLA-C2 combinations are both as-
sociated with ankylosing spondylitis in the Iranian population, Int. J.
Immunogenet. 38 (2011) 403–409.
[74] N. Afshan, M. Bashir, H.N. Tipu, M. Hussain, Optimization of an in-house PCR
method for the detection of HLA-B* 27 alleles, Biomed. Rep. 8 (2018) 385–390.
[75] T. Zhang, Y. Xiao, Y. Wang, Y. Li, L. Zhang, C. Chen, H. Wang, Single-tube mul-
tiplex real-time PCR assay for rapid and reliable detection of HLA-A* 31: 01 allele,
Pharmacogenomics (2018).
[76] Z. Liu, G. Chen, X. Kang, M. Han, R. Chen, C. Chen, H. Wang, A multiplex alle-
le‐specific real‐time polymerase chain reaction assay for HLA‐B* 13: 01 geno-
typing in four Chinese populations, Hla 88 (2016) 164–171.
[77] Z.Z.M. Rani, N.A.A. Murad, S.-M. Then, S.P. Bernam, A. Abdullah, S. Saimun,
S.N. Othman, R.A. Ali, R. Jamal, HLA-B* 15: 02 screening in epileptic patients
using a high resolution melting-real time PCR (HRM-QPCR) method, Neurol. Asia
23 (2018).
[78] N.K. Björkström, P. Riese, F. Heuts, S. Andersson, C. Fauriat, M.A. Ivarsson,
A.T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M.E. Rottenberg,
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK
cell differentiation uncoupled from NK cell education, Blood (2010) blood-2010-
2004-281675.
[79] J.E. Boudreau, K.C. Hsu, Natural killer cell education in human health and disease,
Curr. Opin. Immunol. 50 (2018) 102–111.
[80] H. Wende, M. Colonna, A. Ziegler, A. Volz, Organization of the leukocyte receptor
cluster (LRC) on human chromosome 19q13. 4, Mamm. Genome 10 (1999)
154–160.
[81] K.C. Hsu, S. Chida, D.E. Geraghty, B. Dupont, The killer cell immunoglobulin‐like
receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism,
Immunol. Rev. 190 (2002) 40–52.
[82] N. Yamagata, X. Chen, J. Zhou, J. Li, X. Du, B. Xu, Enzymatic self-assembly of an
immunoreceptor tyrosine-based inhibitory motif (ITIM), Org. Biomol. Chem. 15
(2017) 5689–5692.
[83] C. Yin, L. Hu, H. Huang, Y. Yu, Z. Li, Q. Ji, X. Kong, Z. Wang, J. Yan, J. Yan,
Genetic polymorphism and evolutionary differentiation of Eastern Chinese Han: a
comprehensive and comparative analysis on KIRs, Sci. Rep. 7 (2017) 42486.
[84] L. Thiruchelvam-Kyle, S.E. Hoelsbrekken, P.C. Saether, E.G. Bjørnsen, D. Pende,
S. Fossum, M.R. Daws, E. Dissen, The activating human NK cell receptor KIR2DS2
recognizes a β2-Microglobulin–Independent ligand on Cancer cells, J. Immunol.
198 (2017) 2556–2567.
[85] M. Mori, N. Wichukchinda, R. Miyahara, A. Rojanawiwat, P. Pathipvanich,
N. Tsuchiya, T. Miura, M. Yasunami, K. Ariyoshi, P. Sawanpanyalert, The effect of
KIR2D–HLA-C receptor–ligand interactions on clinical outcome in a HIV-1
CRF01_AE-infected Thai population, Aids 29 (2015) 1607–1615.
[86] B. Maloney, D.K. Lahiri, Epigenetics of dementia: understanding the disease as a
transformation rather than a state, Lancet Neurol. 15 (2016) 760–774.
[87] H. Renz, P.G. Holt, M. Inouye, A.C. Logan, S.L. Prescott, P.D. Sly, An exposome
perspective: early-life events and immune development in a changing world, J.
Allergy Clin. Immunol. 140 (2017) 24–40.
[88] D. Sarigiannis, Assessing the impact of hazardous waste on children’s health: the
exposome paradigm, Environ. Res. 158 (2017) 531–541.
[89] D.K. Lahiri, B. Maloney, Gene× environment interaction by a longitudinal epi-
genome-wide association study (LEWAS) overcomes limitations of genome-wide
association study (GWAS), Epigenomics 4 (2012) 685–699.
[90] D.K. Lahiri, B. Maloney, B.L. Bayon, N. Chopra, F.A. White, N.H. Greig,
J.I. Nurnberger, Transgenerational latent early-life associated regulation unites
environment and genetics across generations, Epigenomics 8 (2016) 373–387.
[91] S. Ogino, J.A. Nowak, T. Hamada, D.A. Milner Jr, R. Nishihara, Insights into pa-
thogenic interactions among environment, host, and tumor at the crossroads of
molecular pathology and epidemiology, Annu. Rev. Pathol. Mech. Dis. (2018).
[92] S. Ogino, J.A. Nowak, T. Hamada, A.I. Phipps, U. Peters, D.A. Milner Jr,
E.L. Giovannucci, R. Nishihara, M. Giannakis, W.S. Garrett, Integrative analysis of
exogenous, endogenous, tumour and immune factors for precision medicine, Gut
67 (2018) 1168–1180.
[93] J. Worrall, What evidence in evidence-based medicine? Philos. Sci. 69 (2002)
S316–S330.
[94] J.H. Howick, The Philosophy of Evidence-based Medicine, John Wiley & Sons,
2011.
[95] R.E. Ashcroft, Current epistemological problems in evidence-based medicine,
Evidence-based Practice in Medicine and Health Care, Springer, 2005, pp. 77–85.
[96] B. Clarke, D. Gillies, P. Illari, F. Russo, J. Williamson, The evidence that evidence-
based medicine omits, Prev. Med. 57 (2013) 745–747.
[97] J. Worrall, Evidence in medicine and evidence‐based medicine, Philos. Compass 2
(2007) 981–1022.
[98] S. Bauer, Modeling population health: reflections on the performativity of epide-
miological techniques in the age of genomics, Med. Anthropol. Q. 27 (2013)
510–530.
[99] M.I. McCarthy, G.R. Abecasis, L.R. Cardon, D.B. Goldstein, J. Little, J.P. Ioannidis,
J.N. Hirschhorn, Genome-wide association studies for complex traits: consensus,
uncertainty and challenges, Nat. Rev. Genet. 9 (2008) 356.
[100] J. Little, J.P. Higgins, J.P. Ioannidis, D. Moher, F. Gagnon, E. von Elm,
M.J. Khoury, B. Cohen, G. Davey-Smith, J. Grimshaw, P. Scheet, M. Gwinn,
R.E. Williamson, G.Y. Zou, K. Hutchings, C.Y. Johnson, V. Tait, M. Wiens,
J. Golding, C. van Duijn, J. McLaughlin, A. Paterson, G. Wells, I. Fortier,
M. Freedman, M. Zecevic, R. King, C. Infante-Rivard, A. Stewart, N. Birkett,
Strengthening the reporting of genetic association studies (STREGA)–an extension
of the STROBE statement, Genet. Epidemiol. 33 (2009) 581–598.
[101] J.A. Hollenbach, S.J. Mack, P.A. Gourraud, R.M. Single, M. Maiers, D. Middleton,
G. Thomson, S.G. Marsh, M.D. Varney, A community standard for im-
munogenomic data reporting and analysis: proposal for a STrengthening the
REporting of Immunogenomic Studies statement, Tissue Antigens 78 (2011)
333–344.
S.A.Y. Ahmadi et al. Biomedicine & Pharmacotherapy 109 (2019) 2203–2209
2209
